跳至主要内容
临床试验/NCT05438992
NCT05438992已完成不适用

Comparing the Effect of Three Different Volumes of Bupivacaine in Infiltration Between Popliteal Artery and Capsule of Knee Block Following Adductor Canal Block in Total Knee Arthroplasty, Prospective Randomized Control Trial.

Cairo University1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2023年12月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
105
试验地点
1
主要终点
visual analogue score ( VAS) for 24 hours postoperatively

研究概览

简要总结

comparing between three different volumes; 15, 20 & 25 ml of 0.25% bupivacaine to determine the best volume of Infiltration Between Popliteal Artery and Capsule of Knee (IPACK) block following adductor canal block (ACB) with the best analgesia and least complications after total knee arthroplasty (TKA)

详细描述

105 participants will be randomized into three groups based on computer generated numbers using online randomization program

Preoperative assessment is conducted on the patients that will be enrolled in this study including history taking, physical examination, and routine laboratory investigations; in the form of CBC, coagulation profile, creatinine, urea, ALT, AST and radiological investigations; according to the medical condition of the patients. All patients should fulfill the inclusion criteria.

a written informed consent form will be obtained from the patients that will be enrolled in the study.

Preoperative:

On the day of surgery, the patient ID will be confirmed in the preparation room, then 18 G cannula will be inserted to the patient, premedication will be given including lactated ringer solution 500 ml, midazolam 2 mg & metoclopramide 10 mg.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing knee arthroscopy surgery.
  • Age between 18 years and 65 years.
  • Both sexes
  • ASA I & ASA II

排除标准

  • Patients' refusal
  • Allergy to any drug that will be used in the study
  • Psychological or mental disorders.
  • Disturbance of Conscious level.
  • Uncooperative patients
  • Coagulopathy
  • Contraindications to spinal anaesthesia (e.g.: severe mitral stenosis)

研究组 & 干预措施

group A

Active Comparator

The patients in this group will be administered 15 ml bupivacaine 0.250 % between the popliteal artery and the capsule of the posterior knee.

干预措施: Bupivacaine 0.25% Preservative-Free Injectable Solution (Drug)

Group B

Active Comparator

The patients in this group will be administered 20 ml bupivacaine 0.250 % between the popliteal artery and the capsule of the posterior knee.

干预措施: Bupivacaine 0.25% Preservative-Free Injectable Solution (Drug)

Group C

Active Comparator

The patients in this group will be administered 25 ml bupivacaine 0.250 % between the popliteal artery and the capsule of the posterior knee.

干预措施: Bupivacaine 0.25% Preservative-Free Injectable Solution (Drug)

结局指标

主要结局

visual analogue score ( VAS) for 24 hours postoperatively

时间窗: 24 hours

assessment of pain score

次要结局

  • morphine consumption(24 hours)
  • morphine complications(24 hours)
  • postoperative hemodynamics(24 hours)
  • first rescue analgesia time(24 hours)
  • sensory block(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heba Omar Ahmed

Associate professor of Anesthesia, pain management & surgical ICU

Cairo University

研究点 (1)

Loading locations...

相似试验